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Abstract: Pharmaceuticals often reach wastewater treatment systems where low removal rates are observed. In 
the present study the potential impact of a mixture of such micro-pollutants on an aerobic granular sludge-
sequencing batch reactor (AGS-SBR) was investigated using a lab-scale bioreactor. COD and P- removals were 
affected due to the load of pharmaceuticals resulting in a decrease of the COD uptake and the P-release during 
the anaerobic feeding phase, but the discharge limits were not exceeded. Nevertheless, both processes returned to 
its normal operation after resuming the pharmaceuticals feeding. The nitrification process was also affected but 
the activity of bacteria responsible for both nitrification steps was able to recover. The exposure to the 
pharmaceuticals induced alterations in the bacterial community structure. 
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Introduction 
Pharmaceutical compounds are emerging environmental contaminants that have been 
detected in various environmental matrices (Santos et al., 2013). Even at low levels, they can 
affect the composition of the microbial communities, and hence disturbing the metabolic 
networks. Aerobic granular sludge (AGS) has been successfully applied for the treatment of 
industrial and domestic wastewaters (Adav et al., 2008) and the implementation of AGS full-
scale facilities has been growing worldwide. The possibility to concomitantly remove carbon, 
nitrogen and phosphorous in a single unit, is one of the attractive aspects of the AGS 
technology since it greatly reduces the plant footprint. Pharmaceuticals are often present in 
influent wastewaters; therefore knowledge on their effect on the AGS microbial community 
and on the biological processes is crucial for the implementation of the AGS technology.All 
subsequent paragraphs are indented and justified. 
Material and Methods 
AGS-SBR was set-up and operated during 86 days as described elsewhere (Amorim et al., 
2014). From day 29 to 57 the synthetic wastewater was amended with a mixture of 
pharmaceuticals from different therapeutic classes. Chemical oxygen demand (COD) was 




-) and phosphate (PO4
3-) were measured using the 
Photometric test kits (Spectroquant®, Merck). The biomass was sampled on different 
operational days and genomic DNA was extracted. PCR-Denaturing gradient gel 
electrophoresis (DGGE) of bacterial 16S rRNA gene was performed according to Amorim et 
al., 2014. DNA pyrosequencing on a 454 Genome Sequencer FLX platform combined with 
bioinformatic analysis was also performed. 
Results and Conclusions 
The load of pharmaceuticals into the AGS-SBR affected the biological processes such as C, N 
and P-removal (Fig. 1.1a,b). The COD removal efficiencies during the anaerobic phase 
slightly decreased but, the maximum COD content at the effluent was below the emission 
limit value (council directive 91/271/EEC). The P-removal was also consistent over the 
operational time. Nevertheless, from the day 28 onwards, the bulk liquid phosphate content 
after the anaerobic feeding period dropped, indicating that polyphosphate accumulating 
organisms’ activity was affected. The load of pharmaceuticals also affected N-removal. An 
increase of the ammonium concentration at the effluent was observed indicating that probably 
ammonia oxidizing bacteria were inhibited but recovered after stopping the feeding. Nitrite 
oxidizing bacteria activity was only partially resumed at the end of the monitoring. 
 
Figure 1.1 COD, P (a) and N (b) removal along AGS-SBR operation. The concentration of COD (), PO43--P 
(x) and NH4+ -N (■) in reactor liquid after anaerobic feeding and COD (), PO43--P (), NH4+ -N (Δ), NO2--N 
(+) and NO3--N (○) effluent are shown. 
 
The DGGE profiling revealed structural differences along bioreactor operation, probably 
related with the adaptation to the pharmaceuticals. Nevertheless, a greatly diverse bacterial 
population was observed, with some bands present along all bioreactor operation. The 
Shannon’s diversity index (H) and the Equitability indexes (E) were similar over the 
operational period. Pyrosequencing analysis indicated that the top abundant phyla within the 
AGS microbial community were Bacteroidetes, Proteobacteria and Actinobacteria. However, 
the proportion of each phylum changed over time. 
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